Enhancing antitumor immunity in Lewis lung cancer through plasma-treated medium-induced activation of dendritic cells
Overall, this research introduces a promising avenue for improving lung cancer treatment using PTM to stimulate an immune response and induce cell death in tumor cells. Further studies will be essential to validate these findings and explore clinical applications.
Authors
- In‐Taek Jang
- Hei Gwon Choi
- Sintayehu K Gurmessa (ORCID: https://orcid.org/0000-0003-1644-2359)
- Nagendra Kumar Kaushik (ORCID: https://orcid.org/0000-0002-4965-5046)
- Chae Bok Lee (ORCID: https://orcid.org/0000-0001-6606-446X)
- Hwa‐Jung Kim (ORCID: https://orcid.org/0000-0002-1127-0909)
- Zhiyuan Jiang
- Naresh Kumar (ORCID: https://orcid.org/0000-0001-7098-8454)
Institutions
- Kwangwoon University (KR)
- Oregon Health & Science University (US)
- Chungnam National University (KR)
- National Institute of Pharmaceutical Education and Research (IN)
Publication Details
- Journal
- Cancer Cell International
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1186/s12935-024-03569-x
- Citations
- 5
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.92
Funders
- National Research Foundation
- National Research Foundation of Korea